spironolactone has been researched along with ng-nitroarginine methyl ester in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (81.82) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Mandarim-de-Lacerda, CA; Meirelles Pereira, LM | 1 |
| Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH | 1 |
| Hoagland, KM; Ito, O; Ito, S; Omata, K; Roman, RJ | 1 |
| Mandarim-de-Lacerda, CA; Pereira, LM | 1 |
| Adler, GK; Martinez, DV; Matsumura, M; Ochoa-Maya, M; Oestreicher, E; Rocha, R; Roubsanthisuk, W; Williams, GH | 1 |
| Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR | 1 |
| Hansen, PB; Jensen, BL; Nørregaard, R; Schjerning, J; Skøtt, O; Sorensen, GL; Uhrenholt, TR | 1 |
| Alonso, MJ; Alvarez, Y; Balfagón, G; Cachofeiro, V; Lahera, V; Márquez-Rodas, I; Salaices, M | 1 |
| Capikova, D; Jendekova, L; Matuskova, J; Paulis, L; Pechanova, O; Simko, F | 1 |
| Asano, Y; Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Minamino, T; Okada, K; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H; Tsukamoto, O; Yamasaki, S; Yulin, L | 1 |
| Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F | 1 |
| Krajcírovicová, K; Lupták, I; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Pincíková, T; Pomsár, J; Simko, F; Stvrtina, S | 1 |
| Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Takahashi, T | 1 |
| Adamcova, M; Hulin, I; Janega, P; Krajcirovicova, K; Matuskova, J; Paulis, L; Pechanova, O; Pelouch, V; Potacova, A; Simko, F; Simko, J | 1 |
| Hayashida, H; Hirakata, H; Iida, M; Ikeda, H; Masutani, K; Toyonaga, J; Tsuruya, K | 1 |
| Brem, AS | 1 |
| Heylen, E; Huang, A; Kaley, G; Sun, D | 1 |
| Coelho-Filho, OR; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Shah, RV | 1 |
| Adler, GK; Khalil, RA; Opsasnick, LA; Pojoga, LH; Reslan, OM; Siddiqui, WT; Williams, GH; Yao, TM | 1 |
| Adler, GK; Baudrand, R; Brooks, D; Garza, AE; Katayama Rangel, IA; Moize, B; Pojoga, LH; Ranjit, S; Romero, JR; Treesaranuwattana, T; Trefts, E; Williams, GH; Yao, TM | 1 |
| Booz, C; Buchner, K; Eichler, K; Frey, N; Gruber-Rouh, T; Gruenewald, LD; Hagenmueller, M; Hardt, SE; Koch, V; Martin, S; März, W; Riffel, JH; Vogl, TJ; Yel, I | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
22 other study(ies) available for spironolactone and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Capillaries; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Heart; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Spironolactone; Verapamil | 2000 |
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases | 2000 |
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Enalapril; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Cortex; Kidney Medulla; Male; Microsomes; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Spironolactone; Tetrazoles | 2001 |
Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Body Weight; Enalapril; Heart; Heart Ventricles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Regression Analysis; Spironolactone; Verapamil | 2001 |
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
Topics: Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Eplerenone; Heart Diseases; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Potassium; Rats; Rats, Wistar; Spironolactone | 2002 |
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone | 2003 |
Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Aorta; Arterioles; Benzoquinones; Calcium; Cells, Cultured; Chromones; Dactinomycin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Heart Ventricles; Humans; In Vitro Techniques; Kidney; Lactams, Macrocyclic; Male; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinones; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Vasoconstriction | 2003 |
Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide.
Topics: Adenine; Adenosine Triphosphate; Aldosterone; Animals; Anti-Arrhythmia Agents; Calcitonin Gene-Related Peptide; Capsaicin; Cyclic GMP; Electric Stimulation; Enzyme Inhibitors; Glyburide; Hypertension; Male; Mesenteric Arteries; Mineralocorticoid Receptor Antagonists; Neurons; NG-Nitroarginine Methyl Ester; Norepinephrine; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Glucocorticoid; Spironolactone; Vasoconstriction; Vasomotor System | 2004 |
Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enzyme Inhibitors; Hypertension, Renal; Kidney; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; S-Nitrosothiols; Spironolactone | 2006 |
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Topics: Actins; Aldosterone; Animals; Blotting, Western; Cytochrome P-450 CYP11B2; Drug Therapy, Combination; Eplerenone; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Immunohistochemistry; Male; Mineralocorticoid Receptor Antagonists; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proliferating Cell Nuclear Antigen; Protein Precursors; Random Allocation; Rats; Rats, Inbred WKY; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Muscle Proteins; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Spironolactone; Ventricular Remodeling | 2007 |
Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cell Proliferation; DNA Replication; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Remodeling | 2007 |
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Malignant; Male; Mineralocorticoid Receptor Antagonists; Nephrosclerosis; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Inbred SHR; RNA, Messenger; Spironolactone; Telmisartan; Transforming Growth Factor beta1 | 2007 |
Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Topics: Animals; Aorta; Arginine; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone | 2008 |
Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.
Topics: Animals; Fibrosis; Hemodynamics; Inflammation; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Osteopontin; Protective Agents; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone | 2009 |
The Janus effect: two faces of aldosterone.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Humans; Kidney Diseases; NG-Nitroarginine Methyl Ester; Rats; Sodium; Spironolactone | 2009 |
Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.
Topics: Acetophenones; Acetylcholine; Aldosterone; Animals; Arterioles; Cerebrum; Cyclic N-Oxides; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; In Vitro Techniques; Male; Mesentery; Muscle, Smooth, Vascular; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Wistar; Spin Labels; Spironolactone; Superoxides; Vasoconstriction; Vasodilation | 2009 |
Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.
Topics: Animals; Cardiac Imaging Techniques; Cardiomegaly; Fibrosis; Heart; Hypertension; Magnetic Resonance Imaging; Mice; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Receptors, Mineralocorticoid; Spironolactone; Stroke Volume | 2014 |
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular System; Caveolin 1; Cyclic GMP; Eplerenone; Heart Injuries; Male; Mice; Mineralocorticoid Receptor Antagonists; Models, Molecular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nucleic Acid Conformation; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Spironolactone; Vasoconstriction; Vasodilation | 2015 |
Striatin heterozygous mice are more sensitive to aldosterone-induced injury.
Topics: Aldosterone; Animals; Blood Pressure; Calmodulin-Binding Proteins; Eplerenone; Kidney; Male; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Pyrroles; Spironolactone; Sulfones | 2020 |
Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload.
Topics: Animals; Blood Pressure; Heart Failure; Homoarginine; Hypertension; Lisinopril; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Spironolactone; Ventricular Remodeling | 2022 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |